Copan White Paper

Self-collected saliva for SARS-CoV-2 detection: evaluation of Copan LolliSponge™

The COVID-19 outbreak caused an unprecedented burden on the healthcare system at a global level. To fight this pandemic, testing, tracking, and tracing were of crucial importance, but limited resources often jeopardized screening programs. Copan LolliSponge™ has been developed in collaboration with the University of Milan to allow saliva collection from non-collaborative patients or when professional assistance is unavailable. This enabled COVID-19 active surveillance programs in fragile communities.

Copan Group

In this second Copan White Paper, we describe in detail all the necessary steps to collect saliva for SARS-CoV-2 detection with LolliSponge™ and analyze its use, processing, and performance in the lab.

Read the full document at the link below:

I'm looking for...

Close Search

We love to talk
to people

Write us to satisfy your curiosity, get information or start a great collaboration!

Contact us for more info

Are you looking
for something?

Use our search tool and be surprised by how easy it is to get right to the point.



Thank you!Your submission
has been received!
Oops! Something went wrong while submitting the form.